Loading...
Chemical structure of PAT-1251

GC30112

PAT-1251

Also known as [3-[[4-(aminomethyl)-6-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]-[(3R,4R)-3-fluoro-4-hydroxypyrrolidin-1-yl]methanone

PAT-1251 is a potent, selective and oral lysyl oxidase-like 2 (LOXL2) inhibitor, with IC50s of 0·71 and 1·17 μM for hLOXL2 and hLOXL3, respectively, and also potently inhibits mouse, rat, and dog LOXL2 (IC50s, 0·10, 0·12, and 0·16 μM, respectively); PAT-1251 is used in the research of fibrotic diseases

ChemicalCAS2007885-39-2MW399.34FormulaC18H17F4N3O3
CAS number
2007885-39-2
Molecular weight
399.34
Formula
C18H17F4N3O3
Solubility
DMSO : ≥ 130 mg/mL (325·54 mM)
InChIKey
ODGXXYXJORZPHE-ZIAGYGMSSA-N
Catalogue number
GC30112
Brand
GLPBIO
Computed properties PubChem CID 122536283 · XLogP 1.5 · TPSA 88.7 Ų · H-bond donors 2
XLogP
1.5
TPSA
88.7 Ų
H-bond donors
2
H-bond acceptors
9
Rotatable bonds
4
Heavy atoms
28

SMILES C1[C@H]([C@@H](CN1C(=O)C2=CC(=CC=C2)OC3=CC(=CC(=N3)C(F)(F)F)CN)F)O

Computed descriptors from PubChem (CID 122536283), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.